Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sotorasib (Standard)

Sotorasib (Standard) is the analytical standard of Sotorasib. This product is intended for research and analytical applications. Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib leads to the regression of KRAS G12C‑mutated locally advanced or metastatic non‑small cell lung cancer (NSCLC) [1][2][3][4][5][6].

Product Specifications

CAS Number

[2296729-00-3]

UNSPSC

12352100

Target

Ras; Reference Standards

Related Pathways

GPCR/G Protein; MAPK/ERK Pathway; Others

Field of Research

Cancer

Smiles

O=C(C=C)N1C[C@H](C)N(C2=NC(N(C3=C(C)C=CN=C3C(C)C)C4=C2C=C(F)C(C5=C(O)C=CC=C5F)=N4)=O)CC1

Molecular Formula

C30H30F2N6O3

Molecular Weight

560.59

References & Citations

[1]Marwan Fakih, et al, Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of AMG 510, a novel small molecule KRASG12Cinhibitor, in advanced solid tumors. Journal of Clinical Oncology.|[2]Karen Rex, et al. Abstract 3090: In vivo characterization of AMG 510 - a potent and selective KRASG12Ccovalent small molecule inhibitor in preclinical KRASG12Ccancer models. Experimental and Molecular Therapeutics.|[3]Brian A. Lanman, et al.Abstract 4455: Discovery of AMG 510, a first-in-human covalent inhibitor of KRASG12C for the treatment of solid tumors. Cancer Chemistry.|[4]Canon J, et al. The clinical KRAS (G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019 Nov;575 (7781) :217-223.|[5]Wu LL, et al. AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research. Discov Oncol. 2023 Jun 7;14 (1) :91.|[6]Ryan MB, et al. KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy. Cell Rep. 2022 Jun 21;39 (12) :110993.

Shipping Conditions

Room temperature

Scientific Category

Reference Standards

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
MBS1086657-01 0.02 mg (E-Coli)

Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Ask
View Details
Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
MBS1086657-02 0.02 mg (Yeast)

Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Ask
View Details
Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
MBS1086657-03 0.1 mg (E-Coli)

Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Ask
View Details
Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
MBS1086657-04 0.1 mg (Yeast)

Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Ask
View Details
Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
MBS1086657-05 0.02 mg (Baculovirus)

Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Ask
View Details
Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)
MBS1086657-06 0.02 mg (Mammalian-Cell)

Recombinant Enterobacter sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Ask
View Details